Characteristics of β-endorphin-induced histamine release from rat serosal mast cells Comparison with neurotensin, dynorphin and compound 48/80

Anita Sydbom

View Related Documents

Abstract

Rat peritoneal mast cells were exposed to the neurohormone and basic opioid peptide beta-endorphin. beta-Endorphin induced a dose-dependent release of histamine from the mast cells. A significant histamine release was found at 5 mgrmol/l of beta-endorphin and maximal release (35% of total) at 20 mgrmol/l. The histamine release process was very rapid and terminated within 30 s at 37°C, and in this sense is very similar to the histamine release induced by compound 48/80 or neurotensin. The histamine release was temperature-dependent showing an optimum release around 30°C, and it was independent of available extracellular calcium, but was inhibited in the presence of high extracellular calcium concentrations. Naloxone, only in very high concentrations (10 mmol/l), inhibited the release, and the very same concentration also inhibited the neurotensin — as well as the compound 48/80-induced histamine release. Cromoglycate and benzalkoniumchloride, a 48/80 antagonist, both produced a progressive dose-dependent inhibition of beta-endorphin-, neurotensin- as well as compound 48/80-induced histamine release. Taken together, the findings indicate that the opioid peptide beta-endorphin induces a selective, energy-dependent release of histamine from peritoneal rat mast cells. The pattern of release has much in common with that of compound 48/80 and other basic peptides, such as neurotensin and substance P. In addition this pattern of release is similar to that induced by dynorphin.

Key words  Histamine liberation - Peritoneal mast cells - Neuropeptides - beta-Endorphin - Compound 48/80 - Neurotensin - Substance P - Naloxone - Disodiumcromoglycate - Benzalkoniumchloride

Send offprint requests to Anita Sydbom at the above address

Fulltext Preview

Image of the first page of the fulltext document